240
Participants
Start Date
July 28, 2025
Primary Completion Date
July 31, 2030
Study Completion Date
July 31, 2030
LY4175408
IV infusion
NOT_YET_RECRUITING
Columbia University, New York
NOT_YET_RECRUITING
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RECRUITING
NEXT Virginia, Fairfax
NOT_YET_RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
RECRUITING
Florida Cancer Specialists - Sarasota, Sarasota
RECRUITING
Sarah Cannon Research Institute, Nashville
NOT_YET_RECRUITING
The Ohio State University (OSU) Wexner Medical Center, Columbus
NOT_YET_RECRUITING
Community Health Network, Indianapolis
NOT_YET_RECRUITING
The University of Chicago Medical Center (UCMC), Chicago
NOT_YET_RECRUITING
Washington University, St Louis
NOT_YET_RECRUITING
Centre Leon Berard, Lyon
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
START Mountain Region, West Valley City
RECRUITING
Stanford Cancer Center, Stanford
NOT_YET_RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Massachusetts General Hospital, Boston
NOT_YET_RECRUITING
John Theurer Cancer Center At Hackensack UMC, Hackensack
NOT_YET_RECRUITING
Kyoto University Hospital, Kyoto
NOT_YET_RECRUITING
National Cancer Center Hospital, Tokyo
RECRUITING
Cancer Institute Hospital of JFCR, Tokyo
NOT_YET_RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
NOT_YET_RECRUITING
Samsung Medical Center, Seoul
NOT_YET_RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
Eli Lilly and Company
INDUSTRY